Tempus

formerly Tempus AIIPO

Tempus is an artificial intelligence company in Chicago, United States, founded in 2015. It has raised $960.0M across 7 rounds, most recently a $200.0M Series G+ in October 2021.

Redefining the future of precision medicine.

Headquarters
Chicago, Illinois
Employees
1001–5000
Founded
2015
Business Model
B2B
Website
tempus.com
Total Funding
$960.0M
Last Round
$200.0M Series G+Oct 2021
Rounds
7
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 7 funding rounds and 7 investors for this company. The full record is or through the API.

About

Tempus AI is a health technology company that uses artificial intelligence and genomic data to enable precision medicine. Founded in 2015 in Chicago, Tempus sequences genomes and analyzes molecular and clinical data to guide treatment decisions in oncology, cardiology, radiology, and pharmacogenomics. The company went public on Nasdaq in June 2024 under ticker TEM.

Summary

It lists 1001–5000 employees. It has raised $960.0M in total across 7 rounds, most recently a $200.0M Series G+ round in Oct 2021. Investors include Ares Management, Baillie Gifford and Franklin Templeton.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPOJun 2024
$410.7M

Sign up to see all 9 events

Funding: Series C through Series G+. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tempus on Indexed.vc
<a href="https://indexed.vc/companies/tempus"><img src="https://indexed.vc/api/badge/company/tempus" alt="Tempus on Indexed.vc" width="260" height="76" /></a>